Filing Manager
DNA Holdings Venture Inc.
Reporting Manager
DNA Holdings Venture Inc.
Symbol
SONM
Shares outstanding
1,121,613 shares
Disclosed Ownership
223,201 shares
Ownership
20%
Form type
SCHEDULE 13D
Filing time
20 Feb 2026, 16:30:08 UTC
Date of event
15 Dec 2025

Key filing fact

DNA Holdings Venture Inc. disclosed 20% ownership in DNA X, Inc. Common Stock, par value $0.001 per share (SONM) on 15 Dec 2025.

Key facts

  • DNA Holdings Venture Inc. filed SCHEDULE 13D for DNA X, Inc. Common Stock, par value $0.001 per share (SONM).
  • Disclosed ownership: 20%.
  • Date of event: 15 Dec 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 20 Feb 2026, 16:30.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (3)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
DNA Holdings Venture Inc. 20% 223,201 0 223,201 /s/ Scott Walker By: Chairman 0002108849
Scott Walker 20% 223,201 0 223,201 /s/ Scott Walker Scott Walker 0001137100
Brock Pierce 20% 223,201 0 223,201 /s/ Brock Pierce Brock Pierce 0002045830
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .